Log In
BCIQ
Print this Print this
 

anti-miR-10b (antagomir-10b)

  Manage Alerts
Collapse Summary General Information
Company Regulus Therapeutics Inc.
DescriptionAntisense oligonucleotide targeting microRNA-10b
Molecular Target MicroRNA-10b (miR-10b)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today